$31.53
-$0.13
(-0.41%)
Quote as of 4:00 PM EST on 02/09/12
Forest Laboratories, Inc.
NYSE:FRX
|
$31.53
|
|
| Today's Open | $31.91 |
|---|---|
| Previous Close | $31.66 |
| Daily Range | $31.35 - $31.92 |
| 52-Week Range | $28.47 - $40.52 |
| Market Cap | $8.42B |
| P/E Ratio | 9.62 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,400,458 |
| Average Daily Volume | 1,865,034 |
| Current FY EPS | $3.70 |
FRX Information
| Description |
|---|
| The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Positive Results on Forest/Gedeon Drug - Analyst Blog
The Zacks Analyst Blog Highlights: Citigroup, JPMorgan Chase, Goldman Sachs Group, Bank of America a
Opening View: DJIA Pointed Higher on China GDP; Financials in the Earnings Spotlight
Forest Beats, Ups View - Analyst Blog
Forest Laboratories Beats Analyst Estimates on EPS
Something to Watch at Forest Laboratories
Earnings Preview: Forest Labs - Analyst Blog
Ring in Generics in 2012 and Beyond - Analyst Blog
Teva Provides In-Line 2012 Outlook - Analyst Blog
UPDATE: Teva Sees Sales, Profit Up In 2012; Authorizes $3 Billion Stock Buyback
